Coca-Cola Femsa SAB de CV Units Cons of 5 Shs -L- + 3 Shs Series -B-BMV: KOF/UBL

New Strong Sell Stocks for December 5th

· Issued by Coca-Cola Femsa SAB de CV Units Cons of 5 Shs -L- + 3 Shs Series -B-

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Akebia Therapeutics, Inc. AKBA is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 26.3% downward over the last 60 days.

Coca-Cola FEMSA, S.A.B. de C.V. KOF is a franchise bottler company. The Zacks Consensus Estimate for its current year earnings has been revised 10.5% downward over the last 60 days.

DENTSPLY SIRONA Inc. XRAY is a dental products company.The Zacks Consensus Estimate for its current year earnings has been revised 6.5% downward over the last 60 days.

View the entire Zacks Rank #5 List.

Zacks Investment Research

Coca-Cola Femsa SAB de CV Units Cons of 5 Shs -L- + 3 Shs Series -B- on 6ix

Story so far

Earlier from Coca-Cola Femsa SAB de CV Units Cons of 5 Shs -L- + 3 Shs Series -B-

Later from Coca-Cola Femsa SAB de CV Units Cons of 5 Shs -L- + 3 Shs Series -B-

All Coca-Cola Femsa SAB de CV Units Cons of 5 Shs -L- + 3 Shs Series -B- news releases